| | PATHWAY: hro01100 | |
Entry |
|
Name |
Metabolic pathways - Helobdella robusta |
Class |
|
Pathway map |
|
Module |
hro_M00006 | Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P [PATH:hro01100] |
hro_M00007 | Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P [PATH:hro01100] |
hro_M00010 | Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:hro01100] |
hro_M00011 | Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate [PATH:hro01100] |
hro_M00038 | Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate [PATH:hro01100] |
hro_M00045 | Histidine degradation, histidine => N-formiminoglutamate => glutamate [PATH:hro01100] |
hro_M00046 | Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate [PATH:hro01100] |
hro_M00053 | Deoxyribonucleotide biosynthesis, ADP/GDP/CDP/UDP => dATP/dGTP/dCTP/dUTP [PATH:hro01100] |
hro_M00067 | Sulfoglycolipids biosynthesis, ceramide/1-alkyl-2-acylglycerol => sulfatide/seminolipid [PATH:hro01100] |
hro_M00128 | Ubiquinone biosynthesis, eukaryotes, 4-hydroxybenzoate + polyprenyl-PP => ubiquinol [PATH:hro01100] |
hro_M00130 | Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4 [PATH:hro01100] |
hro_M00632 | Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P [PATH:hro01100] |
hro_M00882 | Lipoic acid biosynthesis, eukaryotes, octanoyl-ACP => dihydrolipoyl-H [PATH:hro01100] |
hro_M00883 | Lipoic acid biosynthesis, animals and bacteria, octanoyl-ACP => dihydrolipoyl-H => dihydrolipoyl-E2 [PATH:hro01100] |
hro_M00892 | UDP-N-acetyl-D-glucosamine biosynthesis, eukaryotes, glucose => UDP-GlcNAc [PATH:hro01100] |
|
Organism |
Helobdella robusta [GN: hro]
|
Related pathway |
hro00040 | Pentose and glucuronate interconversions |
hro00051 | Fructose and mannose metabolism |
hro00053 | Ascorbate and aldarate metabolism |
hro00130 | Ubiquinone and other terpenoid-quinone biosynthesis |
hro00250 | Alanine, aspartate and glutamate metabolism |
hro00260 | Glycine, serine and threonine metabolism |
hro00270 | Cysteine and methionine metabolism |
hro00280 | Valine, leucine and isoleucine degradation |
hro00290 | Valine, leucine and isoleucine biosynthesis |
hro00330 | Arginine and proline metabolism |
hro00400 | Phenylalanine, tyrosine and tryptophan biosynthesis |
hro00430 | Taurine and hypotaurine metabolism |
hro00440 | Phosphonate and phosphinate metabolism |
hro00512 | Mucin type O-glycan biosynthesis |
hro00513 | Various types of N-glycan biosynthesis |
hro00514 | Other types of O-glycan biosynthesis |
hro00515 | Mannose type O-glycan biosynthesis |
hro00520 | Amino sugar and nucleotide sugar metabolism |
hro00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate |
hro00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin |
hro00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis |
hro00592 | alpha-Linolenic acid metabolism |
hro00601 | Glycosphingolipid biosynthesis - lacto and neolacto series |
hro00603 | Glycosphingolipid biosynthesis - globo and isoglobo series |
hro00604 | Glycosphingolipid biosynthesis - ganglio series |
hro00630 | Glyoxylate and dicarboxylate metabolism |
hro00760 | Nicotinate and nicotinamide metabolism |
hro00770 | Pantothenate and CoA biosynthesis |
hro00900 | Terpenoid backbone biosynthesis |
hro00980 | Metabolism of xenobiotics by cytochrome P450 |
hro00982 | Drug metabolism - cytochrome P450 |
hro00983 | Drug metabolism - other enzymes |
hro01040 | Biosynthesis of unsaturated fatty acids |
|
KO pathway |
|
LinkDB |
|
|
|